| 2024 |
Chang YJ, Lin KT, Shih O, Yang CH, Chuang CY, Fang MH, Lai WB, Lee YC, Kuo HC, (Hung SC, Yao CK, Jeng US, (Chen YR, Sulfated disaccharide protects membrane and DNA damages from arginine-rich dipeptide repeats in ALS., Science advances, vol. 10(8), eadj0347, 2024 |
| 2024 |
Chang JL, Huang CJ, Tsai YC, Chiang NJ, Huang YS, (Hung SC)*, Shan YS*, Lee GB*, An integrated microfluidic system for automatic detection of cholangiocarcinoma cells from bile., Lab on a chip, vol. 24(2), 375-382, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Response to Chen and Liaw., CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, vol. 15(3), e00663, 2024 |
| 2024 |
Chen YJ, Hsiao TH, Lin YC, Jeng WJ, Mao CL, Wei CY, Hsieh YC, Huang CJ, Pan MH, Chen IC, Lin CH, Chen YM, (Yang HI*, Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort., RMD OPEN, vol. 10(2), e003293, 2024 |
| 2024 |
Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, (Yang HI*, Chen CJ, Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(8), 993-1002, 2024 |
| 2024 |
Shen HC, Pan MH, Huang CJ, Yeh HY, (Yang HI*, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC, Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study., GENE, vol. 927, 148660, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(11), 1459-1461, 2024 |
| 2024 |
Lu TY, Wu CD, Huang YT, Chen YC, Chen CJ, (Yang HI, Pan WC*, Exposure to PM(2.5) Metal Constituents and Liver Cancer Risk in REVEAL-HBV., Journal of epidemiology, vol. 34(2), 87-93, 2024 |
| 2024 |
Lin HC, Jeng WJ, (Yang HI*, Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 59(12), 1618-1619, 2024 |
| 2024 |
Teng W, Chang TT, (Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC, Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines., HEPATOLOGY INTERNATIONAL, vol. 18(3), 1066, 2024 |
| 2024 |
Huang JF, Chang TJ, Yeh ML, Shen FC, Tai CM, Chen JF, Huang YH, Hsu CY, Cheng PN, Lin CL, Hung CH, Chen CC, Lee MH, Lee CC, Lin CW, Liu SC, (Yang HI, Chien RN, Kuo CS, Peng CY, Chang ML, Huang CF, Yang YS, Yang HC, Lin HC, Ou HY, Liu CJ, Tseng CH, Kao JH, Chuang WL, Huang CN, Chen PJ, Wang CY, Yu ML, Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus., HEPATOLOGY COMMUNICATIONS, vol. 8(11), e0571, 2024 |
| 2024 |
Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, (Yang HI, Chen HY, Chen CJ, Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC., CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol. S1542-3565(24)00198-8, doi: 10.1016/j.cgh.2024.01.045, 2024 |
| 2024 |
Polaris Observatory Collaborators, (Yang HI); et al, Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories., Journal of hepatology, vol. 80(2), 232-242, 2024 |
| 2024 |
Kim GA, Lim YS, Han S, Choi GH, Choi WM, Choi J, Sinn DH, Paik YH, Lee JH, Lee YB, Cho JY, Heo NY, Yuen MF, Wong VW, Chan SL, (Yang HI, Chen CJ, Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model., ANNALS OF INTERNAL MEDICINE, vol. 177(10), 1308-1318, 2024 |
| 2024 |
Chen YT, Chen TI, Yang TH, Yin SC, Lu SN, Liu XR, Gao YZ, Lin CJ, Huang CW, Huang JF, Yeh ML, Huang CF, Dai CY, Chuang WL, (Yang HI, Yu ML, Lee MH, Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes., AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024 |
| 2024 |
Huang YT, Hsu YC, (Yang HI, Lee MH, Lai TH, Chen CJ, Huang YT, Causal mediation analyses for the natural course of hepatitis C: a prospective cohort study., JOURNAL OF EPIDEMIOLOGY, 2024 |
| 2024 |
S. P. Selvaraj, K. H. Lin, W. C. Lin, M. F. You, T. L. Li*, J. Y Chen*, Rejuvenation of Meropenem by Conjugation with Tilapia Piscidin-4 Peptide Targeting NDM-1 Escherichia coli, ACS OMEGA, vol. 28;9(27):29756-29764, 2024 |
| 2024 |
H. T. Huang, I. W. Lo, Y. C. Lin, G. Y. Liao, Y. S. Lin, L. J. Zhang, T. L. Li, C. C. Liaw*, Y. H. Kuo*, Kaguacidine A: a novel spirohydantoin-containing cucurbitane glycoside from vines of Momordica charantia L., NATURAL PRODUCT RESEARCH, vol. 38 (13), 2179-2186, 2024 |
| 2024 |
Chen, Y.-L.*, Hsieh, J.-W. A., Kuo, S.-C., Kao, C.-T., Tung, C.-C., Yu, J.-H., 「Chang, T.-H.」, Ku, C., Xie, J., Zhang, D., Li, Q., Lin, Y.-C. J.*, Merit of integrating in situ transcriptomics and anatomical information for cell annotation and lineage construction in single-cell analyses of Populus, Genome Biol., vol. 25, 85, 2024 |
